Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients

BACKGROUND: The optimal immunosuppressive regimen in simultaneous pancreas-kidney transplant (SPKT) recipients that prevents acute rejection episodes (AREs) and allows optimal outcome remains elusive. METHODS: This cohort study assessed incidence and time to AREs in 73 consecutive SPKT recipients re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bank, Jonna R., Heidt, Sebastiaan, Moes, Dirk Jan A. R., Roelen, Dave L., Mallat, Marko J. K., van der Boog, Paul J.M., Vergunst, Manon, Jol-van der Zijde, Cornelia M., Bredius, Robbert G. M., Braat, Andries E., Ringers, Jan, van Tol, Maarten J. D., Claas, Frans H. J., Reinders, Marlies E. J., de Fijter, Johannes W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Pancreas and Islet Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361562/
https://www.ncbi.nlm.nih.gov/pubmed/28349124
http://dx.doi.org/10.1097/TXD.0000000000000634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361562/
https://www.ncbi.nlm.nih.gov/pubmed/28349124
http://dx.doi.org/10.1097/TXD.0000000000000634

Ejemplares similares